Monocyte enhancers are highly altered in systemic lupus erythematosus

Epigenomics

Volumn 7, Issue 6, 2015, Pages 921-935

  Shi, Lihua ^a   Zhang, Zhe ^a   Song, Li ^a   Leung, Yiu Tak ^b   Petri, Michelle A ^c   Sullivan, Kathleen E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

enhancer; epigenome; histone methylation; interferon; IRF1; lupus

Indexed keywords

ALPHA2 INTERFERON; HISTONE DEMETHYLASE; HISTONE H3; HISTONE METHYLTRANSFERASE; INTERFERON REGULATORY FACTOR 1; TRANSCRIPTION FACTOR; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; INTERFERON; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; HISTONE METHYLATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION INITIATION SITE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; METHYLATION; TRANSCRIPTION INITIATION;

BINDING SITES; DNA METHYLATION; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLATION; MONOCYTES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTIONAL ACTIVATION;

EID: 84947597215     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.15.47     Document Type: Article

References (67)

1. Clarke A. Economic impact of lupus. Am. J. Manag. Care 7(16 Suppl.), S496-S501 (2001).
2. Garris C, Jhingran P, Bass D, Engel-Nitz NM, Riedel A, Dennis G. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan. J. Med. Econ. 16(5), 667-677 (2013).
3. Garris C, Oglesby A, Sulcs E, Lee M. Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States. Lupus 22(10), 1077-1086 (2013).
4. Baechler EC, Batliwalla FM, Karypis G et al. Interferoninducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl Acad. Sci. USA 100(5), 2610-2615 (2003).
5. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25(3), 383-392 (2006).
6. Kirou KA, Lee C, George S et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 50(12), 3958-3967 (2004).
7. Absher DM, Li X, Waite LL et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 9(8), e1003678 (2013).
8. Coit P, Jeffries M, Altorok N et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J. Autoimmun. 43, 78-84 (2013).
9. Renauer PA, Coit P, Sawalha AH. The DNA methylation signature of human TCRalphabeta+CD4-CD8-double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin. Immunol. 156(1), 19-27 (2015).
10. Zhao M, Liu S, Luo S et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J. Autoimmun. 54, 127-136 (2014).
11. Strickland FM, Hewagama A, Wu A et al. Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. Arthritis Rheum. 65(7), 1872-1881 (2013).
12. Hedrich CM, Rauen T, Apostolidis SA et al. Stat3 promotes IL-10 expression in lupus T cells through transactivation and chromatin remodeling. Proc. Natl Acad. Sci. USA 111(37), 13457-13462 (2014).
13. Hu N, Qiu X, Luo Y et al. Abnormal histone modification patterns in lupus CD4+ T cells. J. Rheumatol. 35(5), 804-810 (2008).
14. Pham TH, Benner C, Lichtinger M et al. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 119(24), e161-171 (2012).
15. Pham TH, Langmann S, Schwarzfischer L et al. CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation. J. Biol. Chem. 282(30), 21924-21933 (2007).
16. Lavin Y, Winter D, Blecher-Gonen R et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159(6), 1312-1326 (2014).
17. Roadmap Epigenomics C, Kundaje A, Meuleman W et al. Integrative analysis of 111 reference human epigenomes. Nature 518(7539), 317-330 (2015).
18. Farh KK, Marson A, Zhu J et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518(7539), 337-343 (2015).
19. Garrett S, Dietzmann-Maurer K, Song L, Sullivan KE. Polarization of primary human monocytes by IFN-gamma induces chromatin changes and recruits RNA Pol II to the TNF-alpha promoter. J. Immunol. 180(8), 5257-5266 (2008).
20. Lee JY, Kim NA, Sanford A, Sullivan KE. Histone acetylation and chromatin conformation are regulated separately at the TNF alpha promoter in monocytes and macrophages. J. Leuk. Biol. 73, 862-871 (2003).
21. Zhang Z, Maurer K, Perin JC, Song L, Sullivan KE. Cytokine-induced monocyte characteristics in SLE. J. Biomed. Biotechnol. 2010, 507475 (2010).
22. Zhang Z, Song L, Maurer K, Bagashev A, Sullivan KE. Monocyte polarization: The relationship of genomewide changes in H4 acetylation with polarization. Genes Immun.12(6),445-456 (2011).
23. Zhang Z, Song L, Maurer K, Petri MA, Sullivan KE. Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun. 11(2), 124-133 (2010).
24. Shi L, Zhang Z, Yu AM et al. The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS ONE 9(5), e93846 (2014).
25. Garrett S, Fitzgerald MC, Sullivan KE. LPS and poly I:C induce chromatin modifications at a novel upstream region of the IL-23 p19 promoter. Inflammation 31(4), 235-246 (2008).
26. Sullivan KE, Reddy AB, Dietzmann K et al. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell. Biol. 27(14), 5147-5160 (2007).
27. Shi L, Perin JC, Leipzig J, Zhang Z, Sullivan KE. Genomewide analysis of interferon regulatory factor I binding in primary human monocytes. Gene 487(1), 21-28 (2011).
28. Trapnell C, Roberts A, Goff L et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7(3), 562-578 (2012).
29. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414), 57-74 (2012).
30. Dennis G, Jr., Sherman BT, Hosack DA et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4(5), P3 (2003).
31. Stormo GD. DNA binding sites: representation and discovery. Bioinformatics 16(1), 16-23 (2000).
32. Matys V, Kel-Margoulis OV, Fricke E et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34(Database issue), D108-110 (2006).
33. Wingender E, Chen X, Fricke E et al. The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 29(1), 281-283 (2001).
34. Hume MA, Barrera LA, Gisselbrecht SS, Bulyk ML. UniPROBE, update 2015: new tools and content for the online database of protein-binding microarray data on protein-DNA interactions. Nucleic Acids Res. 43(Database issue), D117-122 (2015).
35. Garber M, Yosef N, Goren A et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 47(5), 810-822 (2012).
36. Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25(21), 2227-2241 (2011).
37. Chang DH, Angelin-Duclos C, Calame K. BLIMP-1: trigger for differentiation of myeloid lineage. Nat. Immunol. 1(2), 169-176 (2000).
38. Baechler EC, Bauer JW, Slattery CA et al. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol. Med. 13(1-2), 59-68 (2007).
39. Zhang Z, Shi L, Song L, Ephrem E, Petri M, Sullivan K. IRF1 marks activated genes in SLE and can induce target gene expression. Arthritis Rheum. 67(3), 785-796 (2015).
40. Chen S, Ma J, Wu F et al. The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation. Genes Dev. 26(12), 1364-1375 (2012).
41. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130(6), 1083-1094 (2007).
42. Xiang Y, Zhu Z, Han G, Lin H, Xu L, Chen CD. JMJD3 is a histone H3K27 demethylase. Cell Res. 17(10), 850-857 (2007).
43. Satoh T, Takeuchi O, Vandenbon A et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11(10), 936-944 (2010).
44. De Santa F, Narang V, Yap ZH et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 28(21), 3341-3352 (2009).
45. Leung YT, Shi L, Maurer K et al. Interferon regulatory factor 1 and histone H4 acetylation in systemic lupus erythematosus. Epigenetics 10(3), 191-199 (2015).
46. Dai C, Liu Z, Zhou H, Li L. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis. Chin. Med. J. (Engl.) 114(8), 864-868 (2001).
47. Hill GS, Delahousse M, Nochy D et al. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int. 59(1), 304-316 (2001).
48. Kittan NA, Allen RM, Dhaliwal A et al. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS ONE 8(10), e78045 (2013).
49. Heinz S, Benner C, Spann N et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38(4), 576-589 (2010).
50. Kaikkonen MU, Spann NJ, Heinz S et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 51(3), 310-325 (2013).
51. Gorelik G, Richardson B. Aberrant T cell ERK pathway signaling and chromatin structure in lupus. Autoimmun Rev, 8(3), 196-198 (2009).
52. Richardson B, Ray D, Yung R. Murine models of lupus induced by hypomethylated T cells. Methods Mol. Med. 102, 285-294 (2004).
53. Richardson B, Sawalha AH, Ray D, Yung R. Murine models of lupus induced by hypomethylated T cells (DNA hypomethylation and lupus⋯). Methods Mol. Biol. 900, 169-180 (2012).
54. Zhu X, Liang J, Li F, Yang Y, Xiang L, Xu J. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Int. J. Dermatol. 50(6), 697-704 (2011).
55. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140(7), 2197-2200 (1988).
56. Vahedi G, A CP, Hand TW et al. Helper T-cell identity and evolution of differential transcriptomes and epigenomes. Immunol. Rev. 252(1), 24-40 (2013).
57. Vahedi G, Takahashi H, Nakayamada S et al. STATs shape the active enhancer landscape of T cell populations. Cell 151(5), 981-993 (2012).
58. Deshane J, Kim J, Bolisetty S, Hock TD, Hill-Kapturczak N, Agarwal A. Sp1 regulates chromatin looping between an intronic enhancer and distal promoter of the human heme oxygenase-1 gene in renal cells. J. Biol. Chem. 285(22), 16476-16486 (2010).
59. Ahyi AN, Chang HC, Dent AL, Nutt SL, Kaplan MH. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J. Immunol. 183(3), 1598-1606 (2009).
60. Negishi H, Ohba Y, Yanai H et al. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl Acad. Sci. USA 102(44), 15989-15994 (2005).
61. Owen-Hughes T, Workman JL. Remodeling the chromatin structure of a nucleosome array by transcription factortargeted trans-displacement of histones. EMBO J. 15(17), 4702-4712 (1996).
62. Ballare C, Castellano G, Gaveglia L et al. Nucleosomedriven transcription factor binding and gene regulation. Mol. Cell 49(1), 67-79 (2013).
63. Ballare C, Zaurin R, Vicent GP, Beato M. More help than hindrance: nucleosomes aid transcriptional regulation. Nucleus 4(3), 189-194 (2013).
64. Le Dily F, Bau D, Pohl A et al. Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation. Genes Dev. 28(19), 2151-2162 (2014).
65. Sawalha AH, Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupusprone mice. Eur. J. Immunol. 37(5), 1407-1413 (2007).
66. Zhao M, Sun Y, Gao F et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J. Autoimmun. 35(1), 58-69 (2010).
67. Dai Y, Zhang L, Hu C, Zhang Y. Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Clin. Exp. Rheumatol. 28(2), 158-168 (2010).